We’re pleased to share a new publications in the Journal of Neuromuscular Diseases exploring 15 years of experience from the TREAT-NMD Advisory Committee for Therapeutics (TACT), highlighting how expert multidisciplinary […]
TACT
TACT Call for Applicants
Applications are now open for the next TACT review meeting, which will take place in Croatia from 24 to 26 April 2026. TACT continues to support the neuromuscular community by […]
Apply for the TREAT-NMD Advisory Committee for Therapeutics (TACT) December Virtual Review
Are you developing a therapy for a neuromuscular condition and looking for expert guidance to strengthen your strategy? The TREAT-NMD Advisory Committee for Therapeutics (TACT) has one final slot available for its […]
The TREAT-NMD Advisory Committee for Therapeutics (TACT) Convenes in Athens
The TREAT-NMD Advisory Committee for Therapeutics (TACT) recently held its latest meeting at the beginning of May in Athens, Greece. TACT is a globally recognised, multidisciplinary panel of experts that […]
TREAT-NMD Advisory Committee for Therapeutics Call for Applicants
We are excited to announce that we are now accepting applications for our next TREAT-NMD Advisory Committee for Therapeutics (TACT) meetings. There is one spot available for our upcoming  Virtual Meeting […]
Highlights from the TACT Symposium Developing Therapies for Rare Neuromuscular Diseases
The recent TACT Symposium, Developing Therapies in Rare Neuromuscular Diseases, which took place in Boston on the 31st of October, highlighted significant progress made in developing therapies over the past 15 years. Bringing together experts, researchers, clinicians, and stakeholders, the symposium focused on key milestones and lessons learned in improving patient outcomes.
